Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 297,082 | 145,373 | 163,380 | 114,285 | 107,099 |
| Marketable Securities | N/A | N/A | N/A | 14,732 | 40,098 |
| TOTAL | $302,726 | $149,290 | $171,375 | $135,434 | $152,593 |
| Non-Current Assets | |||||
| PPE Net | 2,247 | 2,450 | 2,595 | 2,578 | 2,796 |
| Other Non-Current Assets | 2,275 | 3,633 | 0 | 0 | 0 |
| TOTAL | $4,522 | $6,083 | $2,595 | $2,578 | $2,796 |
| Total Assets | $307,248 | $155,373 | $173,970 | $138,012 | $155,389 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,576 | 1,232 | 2,905 | 3,695 | 2,174 |
| Accrued Expenses | 8,114 | 8,363 | 5,624 | 5,165 | 3,329 |
| TOTAL | $14,690 | $9,595 | $8,529 | $8,860 | $5,503 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $297 | $N/A | $N/A | $N/A |
| Total Liabilities | $14,690 | $9,892 | $8,529 | $8,860 | $5,503 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,643 | 89,446 | 72,633 | 62,687 | 62,351 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -275,695 | -249,180 | -223,326 | -201,177 | -177,800 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 2 |
| TOTAL | $292,558 | $145,481 | $165,441 | $129,152 | $149,886 |
| Total Liabilities And Equity | $307,248 | $155,373 | $173,970 | $138,012 | $155,389 |